Caixin
Dec 01, 2022 04:06 AM
OPINION

Analysis: Chinese Drugmakers Gear Up in Race for Covid Treatments

It will be worth watching to see what company will become the first approved generic drug maker for Paxlovid in China.
It will be worth watching to see what company will become the first approved generic drug maker for Paxlovid in China.

(Blue View) — Chinese drug giant CSPC Pharmaceutical Group won regulatory approval last week to start clinical trials of a Covid-19 medicine it developed. The step was the latest development in the country’s effort to add ammunition for combating the pandemic.

The approval for clinical trials of the pill is the latest advance in CSPC’s Covid-related efforts on various fronts. The company has also launched clinical trials of its mRNA-based vaccine.

You've accessed an article available only to subscribers
VIEW OPTIONS
Share this article
Open WeChat and scan the QR code